OSA treatment history in an upper airway stimulation trial cohort

Objectives: Analyze the obstructive sleep apnea (OSA) treatment history in a group of participants who enrolled in a hypoglossal nerve stimulation trial. Methods: Moderate-severe OSA patients with difficulty adhering to CPAP presented for enrollment in a multicenter trial. Self-reported history on p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ryan J. Soose, Tapan A. Padhya, M. Boyd Gillespie, Oleg Froymovich, Ho-sheng Lin, B. Tucker Woodson
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2017
Materias:
Acceso en línea:https://doaj.org/article/71f58b933444405993bd18265abab759
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:71f58b933444405993bd18265abab759
record_format dspace
spelling oai:doaj.org-article:71f58b933444405993bd18265abab7592021-12-02T12:55:56ZOSA treatment history in an upper airway stimulation trial cohort2095-881110.1016/j.wjorl.2017.05.001https://doaj.org/article/71f58b933444405993bd18265abab7592017-06-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2095881117300483https://doaj.org/toc/2095-8811Objectives: Analyze the obstructive sleep apnea (OSA) treatment history in a group of participants who enrolled in a hypoglossal nerve stimulation trial. Methods: Moderate-severe OSA patients with difficulty adhering to CPAP presented for enrollment in a multicenter trial. Self-reported history on prior OSA medical therapy was collected at enrollment, including OSA diagnosis date, CPAP start and stop dates, oral appliance trial, and reasons for discontinuation or non-adherence. Results: The cohort consisted of 929 participants, 83% male, with a mean age (53.9 ± 10.5) years. Ninety percent (n = 835) had complete CPAP information including 47% (n = 435) who discontinued therapy prior to enrollment and 43% (n = 400) who were still attempting CPAP but had inadequate adherence. Abandonment rates were 60% at 1-year, 73% at 3-years, and 86% at 5-years. Oral appliance therapy was attempted by 171 patients for mean (1.8 ± 2.3) years, with 81% abandonment at 1 year, 89% at 3-years, and 94% at 5-years. Conclusions: In this CPAP-refractory cohort, high rates of CPAP abandonment were reported in the first several years with approximately half of the participants not receiving any treatment despite being diagnosed for >5 years. Close clinical follow-up and consideration of alternative treatment options is indicated in all OSA patients in order to ensure adequate longitudinal care. Keywords: Upper airway stimulation, Hypoglossal nerve stimulation, STAR trial, Obstructive sleep apnea, CPAP failureRyan J. SooseTapan A. PadhyaM. Boyd GillespieOleg FroymovichHo-sheng LinB. Tucker WoodsonKeAi Communications Co., Ltd.articleOtorhinolaryngologyRF1-547SurgeryRD1-811ENWorld Journal of Otorhinolaryngology-Head and Neck Surgery, Vol 3, Iss 2, Pp 79-84 (2017)
institution DOAJ
collection DOAJ
language EN
topic Otorhinolaryngology
RF1-547
Surgery
RD1-811
spellingShingle Otorhinolaryngology
RF1-547
Surgery
RD1-811
Ryan J. Soose
Tapan A. Padhya
M. Boyd Gillespie
Oleg Froymovich
Ho-sheng Lin
B. Tucker Woodson
OSA treatment history in an upper airway stimulation trial cohort
description Objectives: Analyze the obstructive sleep apnea (OSA) treatment history in a group of participants who enrolled in a hypoglossal nerve stimulation trial. Methods: Moderate-severe OSA patients with difficulty adhering to CPAP presented for enrollment in a multicenter trial. Self-reported history on prior OSA medical therapy was collected at enrollment, including OSA diagnosis date, CPAP start and stop dates, oral appliance trial, and reasons for discontinuation or non-adherence. Results: The cohort consisted of 929 participants, 83% male, with a mean age (53.9 ± 10.5) years. Ninety percent (n = 835) had complete CPAP information including 47% (n = 435) who discontinued therapy prior to enrollment and 43% (n = 400) who were still attempting CPAP but had inadequate adherence. Abandonment rates were 60% at 1-year, 73% at 3-years, and 86% at 5-years. Oral appliance therapy was attempted by 171 patients for mean (1.8 ± 2.3) years, with 81% abandonment at 1 year, 89% at 3-years, and 94% at 5-years. Conclusions: In this CPAP-refractory cohort, high rates of CPAP abandonment were reported in the first several years with approximately half of the participants not receiving any treatment despite being diagnosed for >5 years. Close clinical follow-up and consideration of alternative treatment options is indicated in all OSA patients in order to ensure adequate longitudinal care. Keywords: Upper airway stimulation, Hypoglossal nerve stimulation, STAR trial, Obstructive sleep apnea, CPAP failure
format article
author Ryan J. Soose
Tapan A. Padhya
M. Boyd Gillespie
Oleg Froymovich
Ho-sheng Lin
B. Tucker Woodson
author_facet Ryan J. Soose
Tapan A. Padhya
M. Boyd Gillespie
Oleg Froymovich
Ho-sheng Lin
B. Tucker Woodson
author_sort Ryan J. Soose
title OSA treatment history in an upper airway stimulation trial cohort
title_short OSA treatment history in an upper airway stimulation trial cohort
title_full OSA treatment history in an upper airway stimulation trial cohort
title_fullStr OSA treatment history in an upper airway stimulation trial cohort
title_full_unstemmed OSA treatment history in an upper airway stimulation trial cohort
title_sort osa treatment history in an upper airway stimulation trial cohort
publisher KeAi Communications Co., Ltd.
publishDate 2017
url https://doaj.org/article/71f58b933444405993bd18265abab759
work_keys_str_mv AT ryanjsoose osatreatmenthistoryinanupperairwaystimulationtrialcohort
AT tapanapadhya osatreatmenthistoryinanupperairwaystimulationtrialcohort
AT mboydgillespie osatreatmenthistoryinanupperairwaystimulationtrialcohort
AT olegfroymovich osatreatmenthistoryinanupperairwaystimulationtrialcohort
AT hoshenglin osatreatmenthistoryinanupperairwaystimulationtrialcohort
AT btuckerwoodson osatreatmenthistoryinanupperairwaystimulationtrialcohort
_version_ 1718393571384492032